Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases

European Journal of Cancer

Volumn 47, Issue 15, 2011, Pages 2291-2298

  Ercolani, Giorgio ^a   Cucchetti, Alessandro ^a   Cescon, Matteo ^a   Peri, Eugenia ^a   Brandi, Giovanni ^a   Gaudio, Massimo Del ^a   Ravaioli, Matteo ^a   Zanello, Matteo ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adjuvant; Chemotherapy; Colorectal cancer; Cost effectiveness; Liver metastases; Neoadjuvant; Partial hepatectomy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIARRHEA; FEBRILE NEUTROPENIA; HEALTH CARE COST; HUMAN; INTENTION TO TREAT ANALYSIS; LIFE EXPECTANCY; LIVER METASTASIS; NEUTROPENIA; PARTIAL HEPATECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SYSTEMATIC REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; HEALTH CARE COSTS; HEPATECTOMY; HUMANS; LIFE EXPECTANCY; LIVER NEOPLASMS; MARKOV CHAINS; MODELS, ECONOMIC; NEOADJUVANT THERAPY; QUALITY-ADJUSTED LIFE YEARS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053365800     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.05.014     Document Type: Article

References (59)

1. J.J. Tjandra, and M.K. Chan Follow-up after curative resection of colorectal cancer: a meta-analysis Dis Colon Rectum 50 2007 1783 1799 (Pubitemid 350077100)
2. Y. Fong, N. Kemeny, P. Paty, L.H. Blumgart, and A.M. Cohen Treatment of colorectal cancer: hepatic metastasis Semin Surg Oncol 12 1996 219 252 (Pubitemid 26255863)
3. G.D. Leonard, B. Brenner, and N.E. Kemeny Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma J Clin Oncol 23 2005 2038 2048 (Pubitemid 46211384)
4. T.C. Chua, A. Saxena, and W. Liauw Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases Ann Surg Oncol 17 2010 492 501
5. D.B. Mark Economic analysis: methods and end-points R.M. Califf, D.B. Mark, G. Wagner, Acute coronary care 2nd ed. 1995 Mosby-Year Book St. Louis 167 182
6. J.N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072 (Pubitemid 46622116)
7. F.K. Welsh, H.S. Tilney, and P.P. Tekkis Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer 96 2007 1037 1042 (Pubitemid 46608314)
8. H. Nakano, E. Oussoultzoglou, and E. Rosso Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
9. J.R. Beck, J.P. Kassirer, and S.G. Pauker A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method Am J Med 73 1982 883 888 (Pubitemid 13211834)
10. N. Lubezky, R. Geva, and E. Shmueli Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg 33 2009 1028 1034
11. O.F. Bathe, S. Ernst, and F.R. Sutherland A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases BMC Cancer 9 2009 156 158
12. D.J. Gallagher, J. Zheng, and M. Capanu Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases Ann Surg Oncol 16 2009 1844 1851
13. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016 (Pubitemid 351392040)
14. R. Adam, D.A. Wicherts, and R.J. de Haas Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 2008 1635 1641
15. B. Gruenberger, W. Scheithauer, and R. Punzengruber Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 2000 120
16. Y.S. Chun, J.N. Vauthey, and D. Ribero Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival J Gastrointest Surg 11 2007 1498 1504
17. J.C. Hewes, S. Dighe, and R.W. Morris Preoperative chemotherapy and the outcome of liver resection for colorectal metastases World J Surg 31 2007 353 364 (Pubitemid 46183523)
18. M.M. Aloysius, A.M. Zaitoun, and I.J. Beckingham The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study Virchows Arch 451 2007 943 948 (Pubitemid 350060742)
19. D. Tamandl, B. Gruenberger, and B. Herberger Selective resection of colorectal liver metastases Eur J Surg Oncol 33 2007 174 182 (Pubitemid 46336547)
20. H.Z. Malik, S. Farid, and A. Al-Mukthar A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study Ann Surg Oncol 14 12 2007 3519 3526 (Pubitemid 350160110)
21. E. Sperti, R. Faggiuolo, and A. Gerbino Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach Dis Colon Rectum 49 2006 1596 1601 (Pubitemid 44796132)
22. A. Zaniboni, V. Torri, and A. Tinazzi Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey Tumori 91 2005 383 387 (Pubitemid 41719691)
23. A. Wein, C. Riedel, and W. Brückl Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-h infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer Oncology 64 2003 131 138 (Pubitemid 36173378)
24. P.J. Allen, N. Kemeny, and W. Jarnagin Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 2003 109 115
25. K. Tanaka, R. Adam, and H. Shimada Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver Br J Surg 90 2003 963 969 (Pubitemid 37026325)
26. M. Rees, P.P. Tekkis, and F.K. Welsh Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 2008 125 135
27. L. Vigan, A. Ferrero, and R. Lo Tesoriere Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity Ann Surg Oncol 15 2008 2458 2464
28. R.J. de Haas, D.A. Wicherts, and E. Flores R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248 2008 626 637
29. J.S. Tomlinson, W.R. Jarnagin, and R.P. DeMatteo Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 4575 4580 (Pubitemid 350035315)
30. S. Connor, M.G. Hart, and D.N. Redhead Follow-up and outcomes for resection of colorectal liver metastases in Edinburgh Eur J Surg Oncol 33 2007 55 60 (Pubitemid 46131873)
31. R. Niu, T.D. Yan, and J.C. Zhu Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma Ann Surg Oncol 14 2007 2078 2087 (Pubitemid 46988268)
32. H.Z. Malik, K.R. Prasad, and K.J. Halazun Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases Ann Surg 246 2007 806 814 (Pubitemid 350035657)
33. A.C. Wei, P.D. Greig, and D. Grant Survival after hepatic resection for colorectal metastases: a 10-year experience Ann Surg Oncol 13 2006 668 676
34. T.M. Pawlik, C.R. Scoggins, and D. Zorzi Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 2005 715 722
35. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766 (Pubitemid 34547293)
36. M.C. de Jong, S.C. Mayo, and C. Pulitano Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis J Gastrointest Surg 13 2009 2141 2151
37. L. Assumpcao, M.A. Choti, and A.L. Gleisner Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site Arch Surg 143 2008 743 749
38. P. Pessaux, E. Lermite, and O. Brehant Repeat hepatectomy for recurrent colorectal liver metastases J Surg Oncol 93 2006 1 7 (Pubitemid 43038417)
39. I.M. Shaw, M. Rees, and F.K. Welsh Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival Br J Surg 93 2006 457 464
40. T.D. Yan, K.Q. Lian, and D. Chang Management of intrahepatic recurrence after curative treatment of colorectal liver metastases Br J Surg 93 2006 854 859 (Pubitemid 44035258)
41. S. Ishiguro, T. Akasu, and Y. Fujimoto Second hepatectomy for recurrent colorectal liver metastasis: analysis of preoperative prognostic factors Ann Surg Oncol 13 2006 1579 1587 (Pubitemid 44951465)
42. G. Sugawara, M. Isogai, and Y. Kaneoka Repeat hepatectomy for recurrent colorectal metastases Surg Today 35 2005 282 289 (Pubitemid 40562193)
43. K. Tanaka, H. Shimada, and M. Ohta Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer World J Surg 28 2004 482 487 (Pubitemid 38668480)
44. R. Adam, G. Pascal, and D. Azoulay Liver resection for colorectal metastases: the third hepatectomy Ann Surg 238 2003 871 883
45. S. Takahashi, K. Inoue, and M. Konishi Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases Surgery 133 2003 627 634 (Pubitemid 36688317)
46. H. Petrowsky, M. Gonen, and W. Jarnagin Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis Ann Surg 235 2002 863 871 (Pubitemid 34547306)
47. S. Suzuki, T. Sakaguchi, and Y. Yokoi Impact of repeat hepatectomy on recurrent colorectal liver metastases Surgery 129 2001 421 428 (Pubitemid 32289891)
48. A. Muratore, R. Polastri, and H. Bouzari Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol 76 2001 127 132
49. S.T. Karuna, R. Thirlby, and T. Biehl Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis J Surg Oncol 97 2008 396 403 (Pubitemid 351466381)
50. G.S. Gazelle, M.G. Hunink, and K.M. Kuntz Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis Ann Surg 237 2003 544 555 (Pubitemid 38176436)
51. J.W. Tumeh, P.J. Shenoy, and S.G. Moore A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer Am J Clin Oncol 32 2009 49 55
52. M. Tampellini, R. Bitossi, and M.P. Brizzi Pharmacoeconomica comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal carcinoma: a cost-minimization study Tumori 90 2004 44 49 (Pubitemid 38541726)
53. M.R. Gold, J.E. Siegel, and L.B. Russell Cost-effectiveness in Health and Medicine 1996 Oxford University Press New York
54. L.B. Russell, M.R. Gold, and J.E. Siegel The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine JAMA 276 1996 1172 1177 (Pubitemid 26329746)
55. R. De Angelis, E. Grande, and R. Inghelmann Cancer prevalence estimates in Italy from 1970 to 2010 Tumori 93 2007 392 397 (Pubitemid 47403456)
56. O.J. Garden, M. Rees, and G.J. Poston Guidelines for resection of colorectal cancer liver metastases Gut 55 S3 2006 1 8
57. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 3 1999 309 318
58. M.G. House, H. Ito, and M. Gönen Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1600 patients during two decades at a single institution J Am Coll Surg 210 2010 744 752
59. D.G. Power, and N.E. Kenteny Role of adjuvant therapy after resection of colorectal cancer liver metastases J Clin Oncol 28 2010 2300 2309